Our data demonstrated that exogenous HGF treatment reduced hepatic steatosis along with reduction of lipogenesis genes, but it appears that the protective mechanism of HGF is not mediated through modulation of lipid degradation pathway as our data did not show any changes in the expression of β-oxidation-related genes (data not shown). Here, HGF is linked to fatty liver disease.